Fuzzy Panda Research announced that it is short Tenet Healthcare (THC). The firm’s analysis shows Tenet is “back at it again,” appearing to be “doing the same things. And they have added a couple of new tricks like creatively reallocating indirect corporate costs to hospitals to pad their Medicare & Medicaid reimbursements, and management’s pockets.” The firm says it has discovered over 50 False Claims Act lawsuits against Tenet and its hospitals, settling fines for more than $2.5B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- RBC a buyer of hospital stocks on White House memo selloff
- HCA Healthcare price target raised to $410 from $355 at Morgan Stanley
- Tenet Healthcare price target raised to $210 from $175 at Morgan Stanley
- Tenet Healthcare Appoints Lisa Y. Foo as COO
- 3 Undervalued Stocks to Buy Now, 6/5/2025, According to Analysts